Skip to main content
. 2010 Jun 4;31(6):687–695. doi: 10.1038/aps.2010.52

Figure 4.

Figure 4

Inhibitory effect of Gs-Rb1 on mPTP opening and GSK-3 activity in each group. (1) control group; (2) simple hypoxia group; (3) Gs-Rb1 200 μmol/L treatment group; (4) 0.5 μmol/L wortmannin group; (5) wortmannin+Gs-Rb1 group; (6) Ara A 500 μmol/L treatment group; (7) Ara A+Gs-Rb1 group.